Consensus on the treatment of nicotine dependence;Consenso sobre o tratamento da dependência de nicotina

Revista Brasileira de Psiquiatria

Volumn 23, Issue 4, 2001, Pages 200-214

  Marques, A C P R ^a   Campana, A ^a   De Paula Gigliotti, A ^a   Lourenco M T C ^a   Ferreira, M P ^a   Laranjeira, R ^a  

^a Depto Psicobiologia U F Sao Paulo   (Brazil)

Author keywords

Nicotine dependence; Treatment

Indexed keywords

AMFEBUTAMONE; CLONIDINE; NICOTINE; NORTRIPTYLINE;

BRAZIL; HUMAN; MORTALITY; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; REVIEW; SMOKING; TOBACCO DEPENDENCE; UNITED STATES;

EID: 0035660819     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-44462001000400007     Document Type: Review

References (160)

1. International health and tobacco use
2. Cigarette smoking-atributable mortality and years of potential life lost, United States
3. Cigarette smoking and health among adults, United States, 1993
4. Cigarette smoking and health
5. Smoking cessation
6. Tobacco dependence and the nicotine patch: Clinical guidelines for effective use
7. Epidemiology of tobacco use and dependence
8. The development of smoking behavior: Conceptualization and supportive cross-sectional survey data
9. The development of dependence on smoking in children
10. Practice guideline for the treatment of patients with nicotine dependence
11. The human costs of tobacco use (second of two parts)
12. Barriers to good practice in smoking cessation work among pregnant women
13. Strategies for smoking cessation
14. Nicotine delivery kinetics and abuse liability
15. Nicotine and smoking: A review of effects on human performance
16. Treatment of nicotine dependence
17. Rapid arterial kinetics of intravenous and smoked cocaine: Relationship to subjective and cardiovascular effects
18. Emotion, anxiety and smoking
19. Hormonal and subjective effects of smoking the first five cigarettes of the day: A comparison in males and females
20. Recent progress in identifying nicotinic cholinoceptors in mammalian brain
21. The diversity of neuronal nicotinic acetylcholine receptors
22. Understanding drug addiction: Implications for treatment
23. Nicotine dependence, midbrain dopamine system and psychiatric disorders
24. Low concentrations of nicotine increase the firing rate of neurons of the rat ventral tegmental area in vitro
25. Localization of drug reward mechanisms by intracranial injections
26. Autoradiograpbic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons
27. Effects of nicotine on cerebral metabolism
28. The effects of nicotine on brain neurotransmitter systems
29. Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine
30. Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat
31. The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (a5) in the rat central neurons system
32. Measuring nicotine dependence: A review of the fagerstrom tolerance questionnaire
33. Characterization of N-(3H) methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain
34. Nicotine and smoking: A perspective from animal studies
35. Studies on the influence of nicotine infusions on mesolimbic dopamine and locomotor responses to nicotine
36. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
37. Cancer, cigarette smoking and premature death in Europe: A review icluding the recommendations of European cancer experts consensus meeting, Helsinki, October 1996
38. Pharmacological aspects of drug dependence
39. A population-based twin study in women of smoking initiation and nicotine dependence
40. Detrimental effects of nicotine on mood?
41. Initiation of cigarette smoking and subsequent smoking behavior among U.S. high school students
42. Metabolic effects of cigarette smoking
43. Nicotine and smoking: A review of effects on human performance
44. Work and stress as motive for smoking
45. Is nicotine more addictive than cocaine?
46. Arterio-venous differences in plasma concentration of nicotine after cigarette smoking
47. Urinary adrenaline concentrations during 10 days of smoking abstinence
48. The fagerstrom test for nicotine dependence: A revision of the fagerstrom tolerance questionnaire
49. Effects of abstinence from tobacco: A critical review
50. Behavioural pharmacology of nicotine: Multiple mechanisms
51. Withdrawal and reward: Implications for detoxification and relapse prevention
52. Age of initiation, smoking patterns, and risk in a population of working adults
53. Smoking cessation among self-quitters
54. Tobacco dependence curricula in US undergraduate medical education
55. Smoking Status as the new vital sing: Effect on assessment and intervention in patients who smoke
56. Smoking cessation in the spine surgeon's office: A review
57. Treat tobacco dependence and "bend the trend"
58. Validity of the Fagerstrom test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers
59. Imagery and smoking urges: The manipulation of affective content
60. The development and initial validation of a questionnaire of smoking urges
61. Sings and symptoms of tobacco withdrawal
62. Attributes of successful smoking cessation interventions in medical practice: A meta-analysis of 39 controlled trials
63. Smoking Cessation Guidelines and their Cost Effectiveness
64. Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital
65. Clinical practice guideline
66. Group treatment for smoking cessation among persons with schizophrenia
67. Nicotine addic. Primary care
68. Tobacco cessation among patients with depression. Primary Care
69. Promoting tobacco cessation in primary care practice. Primary Care
70. Effect of counselor and client education in nicotine addiction on smoking in substance abusers
71. Smokeless tobacco cessation. Primary Care
72. Aiding reduction of smoking with nicotine replacement mediations: Hope for the recalcitrant smoker?
73. Effects of behavioral and pharmacological treatment on smokeless tobacco users
74. Guidance for commissioners on the cost effectiveness of smoking cessation interventions
75. Self-efficacy: Towards a unifying theory of behavioral change
76. Nicotine replacement therapy: What has been accomplished-can we do better?
77. The nicotine replacement paradox in smoking cessation: How does nicotine gum really work?
78. Physician advice for smoking cessation (Cochrane review)
79. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
80. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice
81. Recent advances in the pharmacotherapy of smoking
82. Characterization of tobacco withdrawal symptoms: Transdermal nicotine reduces hunger and weight gain
83. Nicodermal patch adherence and its correlates
84. Usage patterns of transdermal nicotine when purchased as a non-prescription medicine from pharmacies
85. Public health benefit of over-the-counter nicotine medications
86. The use of nicotine-replacement therapy by hospitalized smokers
87. Usefulness of markers in managing tobacco withdrawal
88. Combined use of nicotine replacement products
89. Helping your patients to quit smoking
90. High dose nicotine patch therapy percentage of replacement and smoking cessation
91. Symptoms of tobacco withdrawal. A replication and extension
92. Effectiveness of nicotine pach and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms
93. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation
94. Do nicotine replacement medications work? A unique standard for nicotine
95. Development of depression during placebo-controlled trials of bupropion for smoking cessation: Case reports
96. Bupropion sustained release and smoking cessation
97. Adding behavioral therapy to medication for smoking cessation
98. The effect of bupropion on nicotine craving and withdrawal
99. Bupropion for smoking cessation: A double-blind, placebo-controlled dose response trial
100. A randomized trial of nortriptyline for smoking cessation
101. Cigarette smoking: Implications for psychiatric illness
102. Is clonidine an effective smoking cessation therapy?
103. Pharmacological adjuncts for the treatment of tobacco dependence
104. Effect of buspirone on withdrawal symptoms associated with smoking cessation
105. Helping patients quit smoking: Lessons Learned in the trenches
106. Behavior therapy and the transdermal nicotine patch: Effects on cessation outcome, affect, and coping
107. Scheduled reduced smoking: Effects on smoking abstinence and potential mechanisms of action
108. Bibliographical analysis of research on smoking cessation therapy
109. Patient referral to a smoking cessation program: Who follows through?
110. Is telephone counselling a useful addiction to physician advice and nicotine replacement therapy in helping patients to stop smoking? A randomized controlled trial
111. Hypnotherapy for smoking cessation (Cochrane review)
112. Health status of older male prisoners: A comprehensive survey
113. The relationship between tobacco use and mental disorders
114. Alcohol abusers who want to quit smoking: Implications for clinical treatment
115. Tobacco addiction: Implications for treatment and cancer prevention
116. Smoking and smoking cessation in cancer patients
117. Cigarette smoking: An epidemiological overview
118. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer
119. Falando sobre tabagismo
120. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men
121. Ten year follow-up of quality of life in patients randomized to receive medical therapy or coronary bypass graft surgery. The Coronary Artery Surgery Study (CASS)
122. Randomized controlled trial of health promotion in general practice for patients at higth cardiovascular risk
123. Randomized controlled trial of follow-up care in general practice of patients with myocardial infarction and angina: Final results of the Southampton Heart Integrated Care Project (SHIP)
124. Comparison of four methods of smoking withdrawal in patients with smoking related disease
125. Smoking withdrawal in hospital patients: Factors associated with outcome
126. Smoking cessation in patients: Two further studies by the British Thoracic society
127. Tobacco and câncer: Epidemiology and the laboratory
128. Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-word' patch users
129. Young teenagers and smoking in 1997
130. Effects of thirty-four adolescent tobacco use cessation and prevention trials on regular users of tobacco products
131. Nicotine dependency and adolescents: Preventing and treating. Primary Care
132. DSM-III-R tobacco dependence and quitting during late adolescence
133. Predictors of smoking cessation in adolescents
134. Socioeconomic status and maternal cigarette smoking before, during and after a pregnancy
135. A children and smoking: The family circle
136. A smoking cessation program at a public antenatal clinic
137. Trends in smoking during pregnancy in England, 1992-7: Quota sampling surveys
138. A prospective intervention study of stopping smoking in pregnancy in a routine antenatal care setting
139. A comparison of withdrawal symptoms from different drug classes
140. Evaluation of a motivational smoking cessation intervention for women in public health clinics
141. Smoking cessation in hospitalized patients. Results of a randomized trial
142. The efficacy of exercise as an aid for smoking cessation in women: A randomized controlled trial
143. Early and late weight gain following smoking cessation in the Lung health study
144. Smokeless tobacco: An addicting drug